Options

First Trust Lists June Series of Target Outcome Buffer ETFs Based on QQQ and EFA

Retrieved on: 
Monday, June 21, 2021
Professional services, Finance, Options, Economy of Chicago, Draft:Buffer investment strategy, Chicago Board Options Exchange

At the end of the Target Outcome Period, the upside cap for the new Target Outcome Period is reset to prevailing market conditions.

Key Points: 
  • At the end of the Target Outcome Period, the upside cap for the new Target Outcome Period is reset to prevailing market conditions.
  • The funds are managed and sub-advised by Cboe Vest Financial LLC (Cboe Vest) using a target outcome strategy or pre-determined target investment outcome.
  • Cboe Vest is the creator of Target Outcome Investments (also known as defined outcome investments) and manager of the longest running Buffer Strategy fund.
  • Target Outcome Investments and Target Outcome ETF are registered trademarks of Cboe Vest Financial.

Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Retrieved on: 
Friday, June 18, 2021
Biotechnology, Surgery, Health, Pharmaceutical, Optical, Corporate finance, Options, Private law, Financial economics, Law, Inheritance, Labour law, Property law, Vesting, Executive compensation, Stock, Employee stock option

The Company granted stock options to purchase up to an aggregate of 64,500 shares of Kala Pharmaceuticals common stock to five new employees.

Key Points: 
  • The Company granted stock options to purchase up to an aggregate of 64,500 shares of Kala Pharmaceuticals common stock to five new employees.
  • The grants were approved by the Compensation Committee and were made as an inducement material to each employee entering into employment with Kala Pharmaceuticals in accordance with NASDAQ Listing Rule 5635(c)(4).
  • The option awards have an exercise price of $5.70 per share, the closing price of Kala Pharmaceuticals common stock on June 15, 2021.
  • Vesting of each option is subject to such employees continued service with Kala Pharmaceuticals through the applicable vesting dates.

KWG Grants Options and Proposes Private Placement of $5 Million Convertible Debenture

Retrieved on: 
Friday, June 18, 2021
Finance, Money, Sports, Options, Corporate finance, Debenture, Debt, Convertible security, Exercise

20,667 options were awarded to the Company's four executive officers, 51,164 to its three non-executive directors and 26,986 to seven consultants.

Key Points: 
  • 20,667 options were awarded to the Company's four executive officers, 51,164 to its three non-executive directors and 26,986 to seven consultants.
  • The options may be exercised at any time prior to their expiry on June 18th, 2026.
  • The Company also announces that it proposes to complete a private placement of debentures convertible at the holder's option at any time or Company's option after the first anniversary date into treasury units at $15 each (a "Unit"), for total proceeds of $5 million.
  • The debentures will bear interest at 12% payable in Units at maturity on June 30, 2023, or upon earlier conversion.

KemPharm Announces Exercise of Existing Warrants and Issuance of Warrants in Private Placement

Retrieved on: 
Friday, June 18, 2021
Finance, Money, Financial markets, Corporate finance, Equity securities, Options, Stock market, Warrant, Security, Private placement, Securities Act

The new warrants are immediately exercisable and have substantially the same terms as the existing warrants, except that the new warrants have an exercise price of $16.50 per share and expire on December 31, 2026.

Key Points: 
  • The new warrants are immediately exercisable and have substantially the same terms as the existing warrants, except that the new warrants have an exercise price of $16.50 per share and expire on December 31, 2026.
  • The aggregate gross proceeds from the exercise of the existing warrants and the issuance of the new warrants are expected to total approximately $39.1 million, before deducting the financial advisory fees.
  • Roth Capital Partners is acting as a financial advisor in connection with the private placement.
  • The securities offered in the private placement have not been registered under the Securities Act of 1933, as amended, or applicable under state securities laws.

Arrival Announces Redemption of Warrants

Retrieved on: 
Friday, June 18, 2021
Finance, Money, Equity securities, Options, Corporate finance, Warrant, Financial markets, NASDAQ

Registered holders of Public Warrants will have until 5:00 p.m. on July 19, 2021 to exercise their Public Warrants.

Key Points: 
  • Registered holders of Public Warrants will have until 5:00 p.m. on July 19, 2021 to exercise their Public Warrants.
  • Any Public Warrants that remain unexercised at 5:00 p.m. New York City time on the Redemption Date will be delisted, void and no longer exercisable, and the holders will have no rights with respect to those Public Warrants, except to receive the Redemption Price.
  • As a result of the redemption, the Public Warrants will cease to be traded on the NASDAQ effective July 20, 2021.
  • Beneficial holders desiring to exercise their Public Warrants should contact the brokerage firm holding their Public Warrants immediately to process their exercise and avoid redemption.

Arrival Announces Effectiveness of Registration Statement

Retrieved on: 
Thursday, June 17, 2021
Corporate finance, Equity securities, Options, Warrant

LONDON and CHARLOTTE, N.C., June 17, 2021 (GLOBE NEWSWIRE) -- Arrival (formerly Arrival Group) (the Company; Ordinary Shares - NASDAQ: ARVL; CUSIP No.

Key Points: 
  • LONDON and CHARLOTTE, N.C., June 17, 2021 (GLOBE NEWSWIRE) -- Arrival (formerly Arrival Group) (the Company; Ordinary Shares - NASDAQ: ARVL; CUSIP No.
  • The registration statement registers for resale certain ordinary shares issued in connection with the business combination as well as ordinary shares issuable upon the exercise of warrants assumed by Arrival in connection with the business combination.
  • The registration statement also registers the issuance of ordinary shares by the Company upon exercise of warrants.
  • Arrival does not give any assurance that Arrival will achieve its expectations.

Big Sky Growth Partners, Inc. Securities to Commence Separate Trading

Retrieved on: 
Thursday, June 17, 2021
Professional services, Finance, Financial markets, Finance, Money, Stock market, Corporate finance, Equity securities, Options, Economy of New York City, NASDAQ, Warrant, Security, Ticker symbol

Big Sky Growth Partners, Inc. (Nasdaq: BSKYU) (the Company) announced today that separate trading of its Class A common stock and warrants underlying the Companys units would commence on June 18, 2021.

Key Points: 
  • Big Sky Growth Partners, Inc. (Nasdaq: BSKYU) (the Company) announced today that separate trading of its Class A common stock and warrants underlying the Companys units would commence on June 18, 2021.
  • The Class A common stock and warrants will trade under the symbols BSKY and BSKYW, respectively.
  • Units not separated will continue to be listed on the Nasdaq Capital Market under the symbol BSKYU.
  • This press release contains statements that constitute forward-looking statements within the meaning of the federal securities laws.

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Retrieved on: 
Thursday, June 17, 2021
Science, Software, Other Science, Networks, Research, Chemicals, Plastics, Technology, Manufacturing, Corporate governance, Executive compensation, Recruitment, NASDAQ, Finance, Options

These grants were made pursuant to the companys 2021 Inducement Equity Incentive Plan, were approved by the compensation committee of the board of directors pursuant to a delegation by the companys board of directors, and were made as a material inducement to such employees acceptance of employment with the company in accordance with Nasdaq Listing Rule 5635(c)(4) as a component of his or her employment compensation.

Key Points: 
  • These grants were made pursuant to the companys 2021 Inducement Equity Incentive Plan, were approved by the compensation committee of the board of directors pursuant to a delegation by the companys board of directors, and were made as a material inducement to such employees acceptance of employment with the company in accordance with Nasdaq Listing Rule 5635(c)(4) as a component of his or her employment compensation.
  • The stock options have an exercise price of $77.51 per share, equal to the closing price of Schrdingers common stock on June 11, 2021.
  • The inducement grants are subject to the terms and conditions of award agreements covering the grants and the companys 2021 Inducement Equity Incentive Plan.
  • Founded in 1990, Schrdinger has over 450 employees and is engaged with customers and collaborators in more than 70 countries.

Cboe Plans to Launch Enhanced Block Trading Service in Canada, Further Expanding BIDS Trading Globally

Retrieved on: 
Thursday, June 17, 2021
Economy of Chicago, Options, Cboe Global Markets, Chicago Board Options Exchange, Economy of the United States, Financial markets, Service companies

CHICAGO, June 17, 2021 /PRNewswire/ --Cboe Global Markets, Inc. (Cboe: CBOE), a market operator and global trading solutions provider, today announced plans to launch Cboe LIS powered by BIDS in Canada, bringing to the region an enhanced block trading service based on a successful model that it first introduced in Europe with BIDS Trading.

Key Points: 
  • CHICAGO, June 17, 2021 /PRNewswire/ --Cboe Global Markets, Inc. (Cboe: CBOE), a market operator and global trading solutions provider, today announced plans to launch Cboe LIS powered by BIDS in Canada, bringing to the region an enhanced block trading service based on a successful model that it first introduced in Europe with BIDS Trading.
  • BIDS operates the largest block trading ATS by volume in the U.S.1, facilitating interaction between the buy-side and sell-side for block trades.
  • Cboe will leverage BIDS' proprietary technology to facilitate block trading on MATCHNow's Conditionals platform.
  • Powered by BIDS technology, Cboe LIS has grown to become one of the largest block trading platforms in Europe.

Xigem Technologies Retains Additional Investor Relations Advisors

Retrieved on: 
Thursday, June 17, 2021
Finance, Money, Corporate finance, Economy, Investment, Options, Warrant, Investor relations

Reaffirming Commitment to Creating Shareholder Value

Key Points: 
  • Toronto, Ontario--(Newsfile Corp. - June 17, 2021) - Xigem Technologies Corporation (CSE: XIGM) (FSE: 2C1) ("Xigem" or the "Company"), a technology provider for the emerging remote economy, today announced that it has retained the services of investor relations and communications firms ("IR Parties") to provide services for the Company.
  • SmallCap Communications offers fully managed social media programs designed to help public companies reach and connect with an investor audience.
  • JBN Partners, LLC, based in South Carolina, is providing investor relations and corporate financial public relations services for an initial term of six months, for a fee of US$100,000.
  • Xigem further advises that the Finder Warrants, issued in conjunction with the private placement that was announced on June 2, 2021, were common share purchase warrants.